상훈 백 is currently the Head of the R&D Center and EVP at Dx & Vx. With over 25 years of experience in biopharmaceutical research and development, they previously served as Managing Director at pH Pharma Co. Ltd., leading an Asia Research Center focused on innovative drug development. They were the inventor of the recombinant Factor VIII “GreenGene F” for hemophilia A treatment and “Hunterase” for Hunter Syndrome, contributing significantly to the biopharmaceutical field. Additionally, 상훈 held several key roles in various organizations, including CTO at BioSparks and a Visiting Scientist at the University of Maryland's Pharmacy School. They earned a Ph.D. and an MBA, furthering their expertise in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices